Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases
Running, not enrolling · Not applicable
Conditions studied: Rheumatic Diseases, COVID-19 Vaccine, COVID-19, SLE
In brief
To establish the efficacy of a community-based POL (Popular Opinion Leader) intervention with two different trainings designed to increase COVID-19 vaccine and booster uptake and reduce hesitancy among social networks of Black individuals with rheumatic conditions. The investigators will also determine the structure and composition of the personal and outreach social networks of POLs.
Key facts
- Study ID
- NCT05822219
- Run by
- Northwestern University
- People needed
- 60
- Starts
- 2024-03-15
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-05-29
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- POLs:
- 18-85 years old; All genders; English-speaking; Self-identify as Black and/or African descent; Received ≥1 dose of a COVID-19 vaccine after 8.31.2022 (bivalent booster or updated COVID-19 vaccine [2023-2024] formula)
- Social network members:
- At least 18 years of age; All genders; English-speaking or Haitian Creole or Spanish-speaking if the POL also speaks Haitian Creole or Spanish; Not have received the updated COVID-19 vaccine 2023-2024 formula; Recent (within 3 months) COVID-19 infection and either undecided or no intention of receiving the vaccine.
You may not qualify if…
- Both POLs and social network members:
- Under 18 years of age Pregnant women Institutionalized or incarcerated Those who are up to date on COVID vaccinations
Where it is running
- Northwestern University — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.